SAN ANTONIO--(BUSINESS WIRE)--Kinetic Concepts, Inc. today announced that its CelluTome™ Epidermal Harvesting System will be showcased at a company-sponsored epidermal grafting education summit April 30–May 1 in Denver, Colo. More than 100 wound care providers will attend to discuss advancing outcomes of care with KCI medical technologies, including the new CelluTome™ Epidermal Harvesting System.
The CelluTome™ Epidermal Harvesting System offers an automated, precise and reproducible process of harvesting autologous non-damaged epidermal tissue.
“The CelluTome™ System allows for a simplified and convenient way to harvest epidermis and provide autologous epidermal micrografts,” said Robert Kirsner, MD, PhD, professor and vice chairman, Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine and chair, Steifel Laboratories. “Our experience, to date, confirms harvesting with minimal, if any, pain and scarring and, most importantly, the ability to heal patients’ wounds.”
Epidermal grafting has been clinically demonstrated to aid closure of acute and chronic wounds. This new skin grafting platform will enable wound care physicians to harvest epidermal grafts while minimizing donor site complications. The product is designed to consistently and reliably harvest epidermis at the DE junction1, which allows skin grafting without the need for donor site anesthesia. The epidermal micrografts harvested with the CelluTome™ System can be used in conjunction with KCI V.A.C.® Therapy.
“The CelluTome™ Epidermal Harvesting System is unlike anything KCI has really offered before,” said Ron Silverman, MD, chief medical officer, KCI. “Our V.A.C.® Therapy System promotes tissue granulation. The epidermal micrografts harvested with the CelluTome™ System promote healing and skin rejuvenation over freshly granulated tissue with minimal damage to the donor site. For patients, this means that we aren’t creating a new wound to save another.”
“The CelluTome™ System makes grafting accessible to a broader range of clinicians and patients than ever before,” said Joe Woody, president & CEO, KCI. “This new product is a complementary and innovative addition to our existing product portfolio of transformational healing solutions. We are looking forward to launching it with physicians in Denver.”
The epidermal grafting education summit will introduce attendees to the science and provide evidence supporting epidermal grafting. Attendees will learn about the process for epidermal harvesting with the CelluTome™ System and review physician experiences and case studies to date. Peer-to-peer discussion about the role of epidermal grafting in the continuum of care will also be discussed.
In conjunction with this event, KCI will present the CelluTome™ System at the Symposium on Advanced Wound Care (SAWC) on May 2–5 in Denver. The CelluTome™ Epidermal Harvesting System will be available in the US in June 2013.
For more information about KCI, please visit www.kci1.com.
About KCI
Kinetic Concepts, Inc. (KCI) is a leading global medical technology company devoted to understanding, developing and commercializing innovative, high-technology transformational healing solutions for customers and patients in more than 25 countries around the world. Headquartered in San Antonio, Texas, KCI is committed to advancing the science of healing and positively impacting patient care by developing customer-driven innovations to meet the evolving needs of healthcare professionals. Proprietary KCI negative pressure technologies have revolutionized the way in which caregivers treat a wide variety of wound types. The V.A.C.® Therapy System has been used on more than 7 million wounds worldwide. Additional information about KCI and its products is available at www.KCI1.com.
The DE (dermoepidermal) junction is the undulating basement membrane zone between superficial (stratum papillare) and basal layer (stratum basale) of the epidermis.
Illustrated Dictionary of Podiatry and Foot Science by Jean Mooney © 2009 Elsevier Limited. All rights reserved.
